163 related articles for article (PubMed ID: 34287815)
1. Membranous nephropathy complicated by immune thrombocytopenia treated with low-density lipoprotein apheresis: a case report and literature review.
Nishizawa K; Yamashita T; Ogawa Y; Kobayashi H
CEN Case Rep; 2022 Feb; 11(1):43-49. PubMed ID: 34287815
[TBL] [Abstract][Full Text] [Related]
2. Successful treatment of coexisting membranous nephropathy and immune thrombocytopenia by eradicating gastric Helicobacter pylori infection: a case report.
Suetsugu R; Sakuma H; Maruyama K; Matsuki M; Ogawa Y; Nakagawa N
CEN Case Rep; 2024 Apr; 13(2):98-103. PubMed ID: 37421572
[TBL] [Abstract][Full Text] [Related]
3. Low-density lipoprotein apheresis for PLA2R-related membranous glomerulonephritis accompanied by IgG4-related tubulointerstitial nephritis.
Nishizawa Y; Honda K; Aoyama Y; Hosoda Y; Tamura T; Horimoto A; Omae K; Higuchi C; Sakura H; Nitta K; Ogawa T
CEN Case Rep; 2020 Nov; 9(4):395-403. PubMed ID: 32557252
[TBL] [Abstract][Full Text] [Related]
4. Thrombotic thrombocytopenic purpura developed during the conservative treatment of anti-phospholipase A
Iio R; Akiyama S; Mitsumoto K; Iwata Y; Okushima H; Shimada K; Ota N; Tomida K; Fushimi H; Shoji T; Matsumoto M; Hayashi T
BMC Nephrol; 2020 Oct; 21(1):431. PubMed ID: 33046023
[TBL] [Abstract][Full Text] [Related]
5. Treatment-resistant PLA2R-negative membranous nephropathy responsive to low-density lipoprotein apheresis.
Szymanski JM; Waldman M; Conry-Cantilena C; West KA
J Clin Apher; 2019 Aug; 34(4):495-498. PubMed ID: 30537217
[TBL] [Abstract][Full Text] [Related]
6. Long-term Low-density Lipoprotein Apheresis in a Patient with Refractory Idiopathic Membranous Glomerulonephritis.
Yabuuchi J; Suwabe T; Mizuno H; Ueno T; Hoshino J; Sekine A; Kawada M; Yamanouchi M; Hayami N; Hiramatsu R; Hasegawa E; Sawa N; Takaichi K; Fujii T; Ohashi K; Ubara Y
Intern Med; 2017; 56(12):1543-1547. PubMed ID: 28626181
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathological characteristics and prognosis of hepatitis B associated membranous nephropathy and idiopathic membranous nephropathy complicated with hepatitis B virus infection.
Wang R; Wu Y; Zheng B; Zhang X; An D; Guo N; Wang J; Guo Y; Tang L
Sci Rep; 2021 Sep; 11(1):18407. PubMed ID: 34526634
[TBL] [Abstract][Full Text] [Related]
8. Coexistence of Anti-Glomerular Basement Membrane Glomerulonephritis and Membranous Nephropathy in a Female Patient with Preserved Renal Function.
Ogawara A; Harada M; Ichikawa T; Fujii K; Ehara T; Kobayashi M
Tohoku J Exp Med; 2017 Dec; 243(4):335-341. PubMed ID: 29269610
[TBL] [Abstract][Full Text] [Related]
9. Anti-PLA
Inoue D; Uchida T; Komatsu S; Sugisaki K; Yamada M; Ogawa H; Ishizu A; Oda T
Kidney Med; 2023 May; 5(5):100625. PubMed ID: 37122392
[TBL] [Abstract][Full Text] [Related]
10. A case of antiglomerular basement membrane glomerulonephritis complicated by membranous nephropathy.
Iguchi A; Ishikawa T; Yamazaki H; Sakamaki Y; Ito T; Watanabe Y; Saeki T; Ito Y; Imai N; Narita I
CEN Case Rep; 2014 May; 3(1):94-99. PubMed ID: 28509257
[TBL] [Abstract][Full Text] [Related]
11. A Refractory Case of Secondary Membranous Nephropathy Concurrent with IgG4-related Tubulointerstitial Nephritis.
Arai H; Toda N; Kamimatsuse R; Nishioka K; Endo S; Akiyama S; Maruyama S; Matsubara T; Yokoi H; Yanagita M
Intern Med; 2018 Oct; 57(19):2873-2877. PubMed ID: 29709946
[TBL] [Abstract][Full Text] [Related]
12. Autoimmune Hepatitis Associated with Immune Thrombocytopenic Purpura.
Ito A; Yoshizawa K; Fujimori K; Morita S; Shigeno T; Maejima T
Intern Med; 2017; 56(2):143-147. PubMed ID: 28090042
[TBL] [Abstract][Full Text] [Related]
13. Malignancy-associated membranous nephropathy with PLA2R double-positive for glomeruli and carcinoma.
Yasuda I; Tokuyama H; Hashiguchi A; Hasegawa K; Uchiyama K; Ryuzaki M; Yasuda M; Mizuno R; Ishidoya S; Wakino S; Itoh H
CEN Case Rep; 2021 May; 10(2):281-286. PubMed ID: 33393071
[TBL] [Abstract][Full Text] [Related]
14. Anti-neutrophil cytoplasmic antibody-associated glomerulonephritis with detection of myeloperoxidase and phospholipase A
Tominaga K; Uchida T; Imakiire T; Itoh K; Shimazaki H; Nakanishi K; Kumagai H; Oshima N
BMC Nephrol; 2018 May; 19(1):120. PubMed ID: 29792176
[TBL] [Abstract][Full Text] [Related]
15. Circulating antibodies to α-enolase and phospholipase A
Kimura Y; Miura N; Debiec H; Morita H; Yamada H; Banno S; Ronco P; Imai H
Clin Exp Nephrol; 2017 Feb; 21(1):117-126. PubMed ID: 26830547
[TBL] [Abstract][Full Text] [Related]
16. Low-density lipoprotein apheresis therapy for steroid- and cyclosporine-resistant idiopathic membranous nephropathy.
Sato Y; Tsunoda S; Nozue T; Pan Q; Wakasugi H; Yoshimura A
Intern Med; 2012; 51(18):2597-602. PubMed ID: 22989833
[TBL] [Abstract][Full Text] [Related]
17. Immune thrombocytopenic purpura presenting in a patient after renal transplant for diabetic nephropathy.
Rashid RM; Nabi Z; Ansari AZ; Qaiser QA
BMC Nephrol; 2018 Mar; 19(1):69. PubMed ID: 29554892
[TBL] [Abstract][Full Text] [Related]
18. Prevalence, diagnostic value and clinical characteristics associated with the presence of circulating levels and renal deposits of antibodies against the M-type phospholipase A2 receptor in idiopathic membranous nephropathy.
Segarra-Medrano A; Jatem-Escalante E; Quiles-Pérez MT; Salcedo MT; Arbós-Via MA; Ostos H; Valtierra N; Carnicer-Cáceres C; Agraz-Pamplona I
Nefrologia; 2014 May; 34(3):353-9. PubMed ID: 24798555
[TBL] [Abstract][Full Text] [Related]
19. Effects of phospholipase A
Yeter HH; Isik Gonul I; Eraslan E; Karacalik C; Ogut B; Guz G
Clin Exp Nephrol; 2021 May; 25(5):488-500. PubMed ID: 33459908
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathological Features of Idiopathic Membranous Nephropathy in 33 Adolescents.
Li C; Li H; Wen YB; Li JN; Lin WF; Cai JF; Duan L; Li Y; Li XM; Li XW
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2017 Aug; 39(4):544-551. PubMed ID: 28877834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]